Ignite Creation Date:
2024-05-06 @ 12:58 PM
Last Modification Date:
2024-10-26 @ 1:06 PM
Study NCT ID:
NCT03893227
Status:
COMPLETED
Last Update Posted:
2021-03-12
First Post:
2019-03-20
Brief Title:
Prevalence of Nasal Hyperreactivity in Chronic Upper Airway Inflammation
Sponsor:
Universitaire Ziekenhuizen KU Leuven
Organization:
Universitaire Ziekenhuizen KU Leuven
Study Overview
Official Title:
Prevalence of Nasal Hyperreactivity in Chronic Upper Airway Inflammation a Prevalence Study
Status:
COMPLETED
Status Verified Date:
2021-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Rhinitis or inflammation of the nasal mucosa can present with nasal obstruction nasal discharge itch or sneezing If the sinusal mucosa is involved as well it is called rhinosinusitis and facial pain or loss of smell is possible Several causes are known such as an underlying allergy allergic rhinitis AR If at least 2 symptoms are present for at least 12 weeks it is called chronic rhinosinusitis CRS
Up to 23 of the AR and CRS patients have symptoms upon exposure to triggers such as sudden temperature changes smoke fragrances a phenomenon called nasal hyperreactivity NHR It is currently not clear why some patients suffer NHR while others do not
In this study the investigators want to determine the prevalence and severity of nasal hyperreactivity in patients with chronic upper airway inflammation To this end patients and healthy controls will be asked to fill out a questionnaire inquiring presence and severity of nasal symptoms upon exposure to particular environmental triggers
Up to 23 of the AR and CRS patients have symptoms upon exposure to triggers such as sudden temperature changes smoke fragrances a phenomenon called nasal hyperreactivity NHR It is currently not clear why some patients suffer NHR while others do not
In this study the investigators want to determine the prevalence and severity of nasal hyperreactivity in patients with chronic upper airway inflammation To this end patients and healthy controls will be asked to fill out a questionnaire inquiring presence and severity of nasal symptoms upon exposure to particular environmental triggers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None